SCHEMBL3185253

SCHEMBL3185253

C=COC1CC(C)CCC1C(C)C

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.49
LMNA P02545 3/20 0.46
TRPA1 O75762 2/20 0.46
TRPM8 Q7Z2W7 2/20 0.46
EPHX1 P07099 3/20 0.43
NFE2L2 Q16236 1/20 0.41
HPGD P15428 1/20 0.40
CYP19A1 P11511 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
KDM4E B2RXH2 1/20 0.39
APOBEC3A P31941 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
GAA P10253 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3185259 1.00 ALDH1A1 (0.49) ALDH1A1LMNATRPA1TRPM8EPHX1
SCHEMBL3239222 1.00 ALDH1A1 (0.49) ALDH1A1LMNATRPA1TRPM8EPHX1
Menthol SCHEMBL1599560 0.88 TRPA1 (0.60) ALDH1A1LMNATRPA1TRPM8EPHX1
SCHEMBL28792394 0.87 ALDH1A1 (0.50) ALDH1A1LMNATRPA1TRPM8EPHX1
SCHEMBL2633946 0.83 ALDH1A1 (0.50) ALDH1A1LMNATRPA1TRPM8EPHX1
SCHEMBL96535 0.83 ALDH1A1 (0.50) ALDH1A1LMNATRPA1TRPM8EPHX1
SCHEMBL7793167 0.82 ALDH1A1 (0.46) ALDH1A1LMNATRPA1TRPM8EPHX1
SCHEMBL16312990 0.79 ALDH1A1 (0.46) ALDH1A1LMNATRPA1TRPM8EPHX1
SCHEMBL197029 0.79 ALDH1A1 (0.57) ALDH1A1LMNATRPA1TRPM8EPHX1
SCHEMBL14480014 0.79 ALDH1A1 (0.57) ALDH1A1LMNATRPA1TRPM8EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119575759-A Positive photosensitive resin composition, photosensitive film, resist underlayer film, resist permanent film, and method for producing film DIC株式会社 2025-03-07 CN disclosed
WO-2024143461-A1 LAMINATE, ELECTRONIC DEVICE, COVER GLASS, AND RESIN COMPOSITION 積水化学工業株式会社 2024-07-04 WO disclosed
CN-118284511-A Laminate and electronic device 积水化学工业株式会社 2024-07-02 CN disclosed
CN-118011733-A Positive photosensitive resin composition, resist film, resist underlayer film, and resist permanent film DIC株式会社 2024-05-10 CN disclosed
EP-3611206-B1 MONOMER MIXTURE AND CURABLE COMPOSITION CONTAINING SAME DAICEL CORP (JP) 2024-02-21 EP disclosed
WO-2023153513-A1 LAMINATE AND ELECTRONIC DEVICE 積水化学工業株式会社 2023-08-17 WO disclosed
US-11667733-B2 Polyvinyl esters and methods related thereto THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2023-06-06 US disclosed
US-11667733-B2 Polyvinyl esters and methods related thereto THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2023-06-06 US disclosed
WO-2023277060-A1 LAMINATE, ELECTRONIC DEVICE, RESIN COMPOSITION AND COVER GLASS 積水化学工業株式会社 2023-01-05 WO disclosed
CN-112125770-B Silicon-center chiral dihydrobenzothiole and preparation method thereof 南方科技大学 2023-01-03 CN disclosed
WO-2003063909-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA INC. (US) 2003-08-07 WO disclosed
US-20030083529-A1 Process for producing vinyl ether compounds DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2003-05-01 US disclosed
WO-2003033603-A1 LEVELLING AGENT AND ANTI-CRATERING AGENT EFKA ADDITIVES B.V. (NL) 2003-04-24 WO disclosed
EP-1288186-A2 Vinyl ether compounds and preparation process thereof Daicel Chemical Industries, Ltd. (JP) 2003-03-05 EP disclosed
EP-0910351-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-28 EP disclosed
EP-0907666-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-14 EP disclosed
WO-1997049736-A2 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed
WO-1997049387-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed
EP-0413068-A1 Process for making an optically active mixture of an n-acyl-amino acid or ester containing at least two chiral centers THE STANDARD OIL COMPANY (US) 1991-02-20 EP disclosed
US-4075237-A Perfluorinated esters of fumaric acid and certain other ethylenically unsaturated poly-basic acid and soil repellant polymers thereof GEIGY CHEMICAL CORPORATION (US) 1978-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030083529-A1 Process for producing vinyl ether compounds SRD5A2, RPS4X, RUVBL2 ALDH1A1 673/4885LMNA 3433/4885TRPA1 3136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.